‌

US Patent 9522923 Selective BACE1 inhibitors

Patent 9522923 was granted and assigned to Eli Lilly and Company on December, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9522923

Date of Patent

December 20, 2016

Patent Application Number

15045305

Date Filed

February 17, 2016

Patent Citations Received

‌

US Patent 12012411 Viral replication inhibitors

‌

US Patent 11702387 Substituted indoline derivatives as dengue viral replication inhibitors

‌

US Patent 11827602 Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Patent Primary Examiner

‌

Kahsay Habte

Patent abstract

The present invention provides a compound of Formula II:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9522923 Selective BACE1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API